Bradycardia Is a Specific Phenotype of Catecholaminergic Polymorphic Ventricular Tachycardia Induced by <i>RYR2</i> Mutations
-
- Miyata Kazuaki
- Department of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Japan Department of Cardiovascular Medicine, Iga City General Hospital, Japan
-
- Ohno Seiko
- Department of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Japan
-
- Itoh Hideki
- Department of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Japan
-
- Horie Minoru
- Department of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Japan
Bibliographic Information
- Other Title
-
- Bradycardia Is a Specific Phenotype of Catecholaminergic Polymorphic Ventricular Tachycardia Induced by RYR2 Mutations.
Search this article
Abstract
<p>Objective Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a lethal inherited disease characterized by ventricular arrhythmias induced by physical exercise or emotional stress. The major cause of CPVT is mutations in RYR2, which encodes the cardiac ryanodine receptor channel. Recent advances in sequencing technology have yielded incidental findings of RYR2 variants in other cardiac diseases. Analyzing the characteristics of RYR2 variants related to CPVT will be useful for differentiation from those related to other cardiac diseases. We examined the phenotypic characteristics of patients with RYR2 variants. </p><p>Methods Seventy-nine probands carrying RYR2 variants whose diagnoses were either CPVT (n=68) or long QT syndrome (LQTS; n=11) were enrolled. We compared the characteristics of the electrocardiogram (ECG) and the location of the RYR2 mutations-N-terminal (NT), central region (CR) or C-terminal (CT)-between the two patient groups. </p><p>Results Using the ECGs available from 53 probands before β-blocker therapies, we analyzed the heart rates (HRs). CPVT probands showed bradycardia more frequently (25/44; 57%) than LQTS probands (1/9; 11%; p=0.024). In CPVT patients, 20 mutations were located in NT, 25 in CR and 23 in CT. In LQTS patients, 5 mutations were located in NT, 2 in CR and 4 in CT. There were no significant differences in the locations of the RYR2 mutations between the phenotypes. </p><p>Conclusion Bradycardia was highly correlated with the phenotype of CPVT. When a clinically-diagnosed LQTS patient with bradycardia carries an RYR2 mutation, we should be careful to avoid making a misdiagnosis, as the patient may actually have CPVT. </p>
Journal
-
- Internal Medicine
-
Internal Medicine 57 (13), 1813-1817, 2018-07-01
The Japanese Society of Internal Medicine